Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Jacques Body

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 21, 2015
Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancerAlison T Stopeck, Karim Fizazi, Jean-Jacques Body, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2007
Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastasesAllan Lipton, Guenther G Steger, Jazmin Figueroa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Extended efficacy and safety of denosumab in breast cancer patients with bone metastases not receiving prior bisphosphonate therapyAllan Lipton, Guenther G Steger, Jazmin Figueroa, et al.
European Journal of Cancer (Oxford, England : 1990)|June 22, 2015
Hypocalcaemia in patients with metastatic bone disease treated with denosumabJean-Jacques Body, Henry G Bone, Richard H de Boer, et al.
Cancer|September 7, 2012
Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acidCharles S Cleeland, Jean-Jacques Body, Alison Stopeck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge ConferenceRobert E Coleman, Theresa A Guise, Allan Lipton, et al.
Journal of Bone Oncology|April 18, 2017
Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOGPeyman Hadji, Matti S Aapro, Jean-Jacques Body, et al.
BMJ (Clinical Research Ed.)|May 2, 2023
Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trialsMina Nicole Händel, Isabel Cardoso, Cecilie von Bülow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Advances in treating metastatic bone cancer: summary statement for the First Cambridge ConferenceAllan Lipton, James R Berenson, Jean-Jacques Body, et al.
Autoimmunity Reviews|July 6, 2010
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practiceJean-Claude Souberbielle, Jean-Jacques Body, Joan M Lappe, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 21, 2015
Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancerAlison T Stopeck, Karim Fizazi, Jean-Jacques Body, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2007
Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastasesAllan Lipton, Guenther G Steger, Jazmin Figueroa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Extended efficacy and safety of denosumab in breast cancer patients with bone metastases not receiving prior bisphosphonate therapyAllan Lipton, Guenther G Steger, Jazmin Figueroa, et al.
European Journal of Cancer (Oxford, England : 1990)|June 22, 2015
Hypocalcaemia in patients with metastatic bone disease treated with denosumabJean-Jacques Body, Henry G Bone, Richard H de Boer, et al.
Cancer|September 7, 2012
Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acidCharles S Cleeland, Jean-Jacques Body, Alison Stopeck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge ConferenceRobert E Coleman, Theresa A Guise, Allan Lipton, et al.
Journal of Bone Oncology|April 18, 2017
Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOGPeyman Hadji, Matti S Aapro, Jean-Jacques Body, et al.
BMJ (Clinical Research Ed.)|May 2, 2023
Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trialsMina Nicole Händel, Isabel Cardoso, Cecilie von Bülow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Advances in treating metastatic bone cancer: summary statement for the First Cambridge ConferenceAllan Lipton, James R Berenson, Jean-Jacques Body, et al.
Autoimmunity Reviews|July 6, 2010
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practiceJean-Claude Souberbielle, Jean-Jacques Body, Joan M Lappe, et al.
Pageof 14